02, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that the Agenzia Italiana del Farmaco ...

Buy GNTA near 5.1 target n/a stop loss @ 5.09. Details The technical summary data tells us to buy GNTA near 5.1, but there is no current upside target from the summary table. In this case we should ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Danaher (DHR – Research Report) and Genenta Science SpA Sponsored ADR (GNTA – Research Report). Danaher (DHR ...

Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.

We recently published a list of 10 Best Italian Stocks To Buy Now. In this article, we are going to take a look at where Genenta Science S.p.A. (NASDAQ:GNTA) stands against the other best Italian ...

Genenta Science Spa is listed on the CBOE trading with ticker code GNTA.US. It has a market capitalisation of $104.38m, with approximately 18.22m shares in issue. Over the last year, Genenta ...